<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Iron is essential for cell proliferation, <z:chebi fb="4" ids="30413">heme</z:chebi> synthesis, and a variety of cellular metabolic processes </plain></SENT>
<SENT sid="1" pm="."><plain>In most cells, transferrin receptor-mediated endocytosis is a major pathway for cellular iron uptake </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, transferrin receptor 2 (TfR2), another receptor for transferrin, was cloned </plain></SENT>
<SENT sid="3" pm="."><plain>High levels of expression of TfR2 <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) occur in the liver, as well as in HepG2 (a <z:e sem="disease" ids="C0019204" disease_type="Neoplastic Process" abbrv="">hepatoma</z:e> cell line) and K562 (an erythroid <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell line) </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, TfR2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was analyzed in hematological cell lines, <z:mpath ids='MPATH_458'>normal</z:mpath> erythroid cells at various stages of differentiation, and <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="C0026986,C0033027" disease_type="Neoplastic Process" abbrv="">preleukemia</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>High levels of TfR2 expression occurred in <z:hpo ids='HP_0000001'>all</z:hpo> of the erythroid cell lines that were examined </plain></SENT>
<SENT sid="6" pm="."><plain>Erythroid-specific expression of TfR2 protein in bone marrow cells was confirmed by immunohistochemical staining </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of TfR2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was high in <z:mpath ids='MPATH_458'>normal</z:mpath> CD34(+) erythroid precursor cells, and levels decreased during erythroid differentiation in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>Levels of expression of TfR2-alpha <z:chebi fb="2" ids="33699">mRNA</z:chebi> were significantly higher in <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukemia</z:e> (M6) marrow samples than in nonmalignant control marrow samples </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, relatively higher levels of TfR2-alpha <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression occurred in some samples of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> that had <z:hpo ids='HP_0012132'>erythroid hyperplasia</z:hpo> in bone marrow, <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> M1, M2, and <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Expression profiles of <z:mpath ids='MPATH_458'>normal</z:mpath> members of the erythroid lineage suggest that TfR2-alpha may be a useful marker of early erythroid precursor cells </plain></SENT>
<SENT sid="11" pm="."><plain>The clinical significance of TfR2-alpha expression in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells remains to be determined </plain></SENT>
</text></document>